Review



3170007b  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    fluidigm 3170007b
    3170007b, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc12866138-15-8-5
    Average 92 stars, based on 2 article reviews
    3170007b - by Bioz Stars, 2026-09
    92/100 stars

    Images

    Related Articles

    Mass Cytometry:

    Article Title: BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis
    Article Snippet: 170Er anti-CD3 (clone SP34-2) , Fluidigm , Cat #3170007B.



    Similar Products

    92
    fluidigm 3170007b
    3170007b, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc12866138-15-8-5
    Average 92 stars, based on 1 article reviews
    3170007b - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm 170er anti cd3
    170er Anti Cd3, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc12866138-15-0-5
    Average 92 stars, based on 1 article reviews
    170er anti cd3 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm 3170007b apc anti mr1 5 op ru tetramer nih tetramer core n a 163dy anti anti apc fluidigm
    3170007b Apc Anti Mr1 5 Op Ru Tetramer Nih Tetramer Core N A 163dy Anti Anti Apc Fluidigm, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pm41529694-273-106-117
    Average 92 stars, based on 1 article reviews
    3170007b apc anti mr1 5 op ru tetramer nih tetramer core n a 163dy anti anti apc fluidigm - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm 2030 01 170er anti cd3
    2030 01 170er Anti Cd3, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pm41529694-273-99-104
    Average 92 stars, based on 1 article reviews
    2030 01 170er anti cd3 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm sp34

    Sp34, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc08633018-3-6-2
    Average 92 stars, based on 1 article reviews
    sp34 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm cd3
    Macrophage phenotypes, CLSs, and T cell infiltration in AT one year after VSG (A and B) Tissue-resident macrophages (CD64 + CD45 + stromal vascular cells) in VAT were significantly suppressed after VSG (n = 3) compared to sham (n = 3) (A), with less CD206 expression (a classic M2 macrophage marker) and less expression of activation markers CD11c, HLA-DR, and CD169 (B). (C–F) (C) CLS density (expressed as Δchange from D0) trended to slightly increased after sham surgery, but was significantly reduced in VAT after VSG suggested reduced inflammation in the VAT. This was VAT-compartment specific, with SAT (D) demonstrating increases in CLSs after both sham surgery and VSG. Similar trends were seen with <t>CD3</t> + T cells, with a decrease after VSG in VAT (E) but not SAT (F). ∗p < 0.05, sham vs. VSG; #p = 0.05, sham vs. VSG. Data reported as group average ±SEM. See also <xref ref-type=Figure S3 . " width="250" height="auto" />
    Cd3, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc08633018-3-0-2
    Average 92 stars, based on 1 article reviews
    cd3 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    fluidigm sp34 2
    Macrophage phenotypes, CLSs, and T cell infiltration in AT one year after VSG (A and B) Tissue-resident macrophages (CD64 + CD45 + stromal vascular cells) in VAT were significantly suppressed after VSG (n = 3) compared to sham (n = 3) (A), with less CD206 expression (a classic M2 macrophage marker) and less expression of activation markers CD11c, HLA-DR, and CD169 (B). (C–F) (C) CLS density (expressed as Δchange from D0) trended to slightly increased after sham surgery, but was significantly reduced in VAT after VSG suggested reduced inflammation in the VAT. This was VAT-compartment specific, with SAT (D) demonstrating increases in CLSs after both sham surgery and VSG. Similar trends were seen with <t>CD3</t> + T cells, with a decrease after VSG in VAT (E) but not SAT (F). ∗p < 0.05, sham vs. VSG; #p = 0.05, sham vs. VSG. Data reported as group average ±SEM. See also <xref ref-type=Figure S3 . " width="250" height="auto" />
    Sp34 2, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3170007b/Anti-Human+CD3e+(SP34-2)-170Er/pmc08277797-28-6-8
    Average 92 stars, based on 1 article reviews
    sp34 2 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    Journal: iScience

    Article Title: A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesity

    doi: 10.1016/j.isci.2021.103421

    Figure Lengend Snippet:

    Article Snippet: CD3 , Fluidigm , Cat#3170007B; Clone: SP34-2.

    Techniques: Recombinant, Blocking Assay, Staining, Antibody Labeling, Multiplex Assay, Software

    Macrophage phenotypes, CLSs, and T cell infiltration in AT one year after VSG (A and B) Tissue-resident macrophages (CD64 + CD45 + stromal vascular cells) in VAT were significantly suppressed after VSG (n = 3) compared to sham (n = 3) (A), with less CD206 expression (a classic M2 macrophage marker) and less expression of activation markers CD11c, HLA-DR, and CD169 (B). (C–F) (C) CLS density (expressed as Δchange from D0) trended to slightly increased after sham surgery, but was significantly reduced in VAT after VSG suggested reduced inflammation in the VAT. This was VAT-compartment specific, with SAT (D) demonstrating increases in CLSs after both sham surgery and VSG. Similar trends were seen with CD3 + T cells, with a decrease after VSG in VAT (E) but not SAT (F). ∗p < 0.05, sham vs. VSG; #p = 0.05, sham vs. VSG. Data reported as group average ±SEM. See also <xref ref-type=Figure S3 . " width="100%" height="100%">

    Journal: iScience

    Article Title: A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesity

    doi: 10.1016/j.isci.2021.103421

    Figure Lengend Snippet: Macrophage phenotypes, CLSs, and T cell infiltration in AT one year after VSG (A and B) Tissue-resident macrophages (CD64 + CD45 + stromal vascular cells) in VAT were significantly suppressed after VSG (n = 3) compared to sham (n = 3) (A), with less CD206 expression (a classic M2 macrophage marker) and less expression of activation markers CD11c, HLA-DR, and CD169 (B). (C–F) (C) CLS density (expressed as Δchange from D0) trended to slightly increased after sham surgery, but was significantly reduced in VAT after VSG suggested reduced inflammation in the VAT. This was VAT-compartment specific, with SAT (D) demonstrating increases in CLSs after both sham surgery and VSG. Similar trends were seen with CD3 + T cells, with a decrease after VSG in VAT (E) but not SAT (F). ∗p < 0.05, sham vs. VSG; #p = 0.05, sham vs. VSG. Data reported as group average ±SEM. See also Figure S3 .

    Article Snippet: CD3 , Fluidigm , Cat#3170007B; Clone: SP34-2.

    Techniques: Expressing, Marker, Activation Assay

    Diversity of myeloid and lymphoid immune cells one month after VSG (A–C) Our short-term study (A) was designed to characterize early immunocyte changes in a group of animals with matched weight loss following VSG to the long-term study (B). VSG promoted M2-like macrophage polarization, increased the number of regulatory T cells, and decreased the number of proliferating T cells in the adipose tissue. Fold-change from baseline in PBLs, SAT, and VAT in the ratio of: (C) M2/M1 macrophages (M1: CD206 + CD11c + , M2: CD206 + CD11c − of CD14 + CD68 + CD3 - lym), M2/M1 in SAT n = 1, all others n = 2. (D) Tregs (FoxP3 + CD4 + of CD3 + lym). (E) t -SNE projection of 26,400 myeloid cells (CD3 − CD20 - /CD45 + lym) sampled equally from PBLs (n = 2), SAT (n = 2), and VAT (n = 2) at D0 and D28 after VSG. (F) 12 individual FlowSOM-identified myeloid populations from the t -SNE projection in (E) as fold change from D0. (G) Heatmap showing mean expression of indicated markers across the 12 FlowSOM myeloid populations. (H) t -SNE projection of 4860 Tregs (CD25 + CD127 - /CD4 + lym) sampled equally from PBLs (n = 2), SAT (n = 2), and VAT (n = 2) at D0 and D28 after VSG. (I) Six individual FlowSOM-identified Treg populations from the t -SNE projects in (H) as fold change from D0. (J) Heatmap showing mean expression of indicated markers across the six FlowSOM Treg populations. Data reported as group average ±SEM. See also , , and , and and .

    Journal: iScience

    Article Title: A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesity

    doi: 10.1016/j.isci.2021.103421

    Figure Lengend Snippet: Diversity of myeloid and lymphoid immune cells one month after VSG (A–C) Our short-term study (A) was designed to characterize early immunocyte changes in a group of animals with matched weight loss following VSG to the long-term study (B). VSG promoted M2-like macrophage polarization, increased the number of regulatory T cells, and decreased the number of proliferating T cells in the adipose tissue. Fold-change from baseline in PBLs, SAT, and VAT in the ratio of: (C) M2/M1 macrophages (M1: CD206 + CD11c + , M2: CD206 + CD11c − of CD14 + CD68 + CD3 - lym), M2/M1 in SAT n = 1, all others n = 2. (D) Tregs (FoxP3 + CD4 + of CD3 + lym). (E) t -SNE projection of 26,400 myeloid cells (CD3 − CD20 - /CD45 + lym) sampled equally from PBLs (n = 2), SAT (n = 2), and VAT (n = 2) at D0 and D28 after VSG. (F) 12 individual FlowSOM-identified myeloid populations from the t -SNE projection in (E) as fold change from D0. (G) Heatmap showing mean expression of indicated markers across the 12 FlowSOM myeloid populations. (H) t -SNE projection of 4860 Tregs (CD25 + CD127 - /CD4 + lym) sampled equally from PBLs (n = 2), SAT (n = 2), and VAT (n = 2) at D0 and D28 after VSG. (I) Six individual FlowSOM-identified Treg populations from the t -SNE projects in (H) as fold change from D0. (J) Heatmap showing mean expression of indicated markers across the six FlowSOM Treg populations. Data reported as group average ±SEM. See also , , and , and and .

    Article Snippet: CD3 , Fluidigm , Cat#3170007B; Clone: SP34-2.

    Techniques: Expressing

    Journal: iScience

    Article Title: A nonhuman primate model of vertical sleeve gastrectomy facilitates mechanistic and translational research in human obesity

    doi: 10.1016/j.isci.2021.103421

    Figure Lengend Snippet:

    Article Snippet: CD3 , Fluidigm , Cat#3170007B; Clone: SP34-2.

    Techniques: Recombinant, Blocking Assay, Staining, Antibody Labeling, Multiplex Assay, Software